Table 2 Results of scoring of stromal and intracellular TNC, and FN of stage I and II OTSCC patients
N (%) | All patients ( n =98) | OUH ( n =59) | KUH ( n =14) | UOPECCAN ( n =8) | CEONC ( n =17) |
|---|---|---|---|---|---|
Frequencies of TNC and FN scores in different hospitals, stages I–II | |||||
Stromal TNC | |||||
Negative | 26 (27) | 20 (34) | – | 2 (25) | 4 (23) |
Moderate | 65 (66) | 35 (59) | 11 (79) | 6 (75) | 13 (77) |
Abundant | 7 (7) | 4 (7) | 3 (21) | – | – |
Cellular TNC | |||||
Negative | 60 (61) | 32 (54) | 12 (86) | 4 (50) | 12 (71) |
Positive | 38 (39) | 27 (46) | 2 (14) | 4 (50) | 5 (29) |
Stromal FN | |||||
Negative | 35 (36) | 27 (46) | 3 (21) | 1 (13) | 4 (24) |
Moderate | 55 (56) | 28 (47) | 10 (72) | 6 (74) | 11 (64) |
Abundant | 8 (8) | 4 (7) | 1 (7) | 1 (13) | 2 (12) |
Cellular FN | |||||
Negative | 63 (64) | 47 (80) | 7 (50) | 4 (50) | 5 (29) |
Positive | 35 (36) | 12 (20) | 7 (50) | 4 (50) | 12 (71) |
